Alternatives to Bloomsbury Pharma AI

Develops a computational model of the human body for drug discovery and development.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

AI platform for accelerating novel peptide therapeutic discovery and development.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

MeNow leverages AI and nature to discover and develop functional ingredients for personalized cosmetics R&D and sales.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

AI-powered research assistant for scientific literature review and data extraction.

Microbiome technology platform for developing novel therapeutics.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.